Cargando…

Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases

Central nervous system (CNS) toxicity has been reported in approximately 10-30% of patients receiving intravenous infusions of ifosfamide. Encephalopathy is a rare but serious CNS adverse reaction in these patients, and although usually transient and reversible, may cause persistent neurological dys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, You-Jung, Kim, Ji-Young, Moon, Jei-Won, You, Rae-Mi, Park, Jeong-Yeol, Nam, Joo-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253870/ https://www.ncbi.nlm.nih.gov/pubmed/22247713 http://dx.doi.org/10.4143/crt.2011.43.4.260

Ejemplares similares

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review
por: Lee Brink, Amanda, et al.
Publicado: (2020)

Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
por: Vakiti, Anusha, et al.
Publicado: (2018)

Ifosfamide-induced Encephalopathy Precipitated by Aprepitant: A Rarely Manifested Side Effect of Drug Interaction
por: Kataria, Pritam Sureshchandra, et al.
Publicado: (2017)

The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
por: Kim, Min-Gyun, et al.
Publicado: (2012)

Fatal Encephalopathy Caused by a Urea Cycle Disorder
por: Park, Soo-Hyun, et al.
Publicado: (2021)

Analysis and Comparison of Somatic Mutations in Paired Primary and Recurrent Epithelial Ovarian Cancer Samples
por: Kim, Yong-Man, et al.
Publicado: (2014)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
por: Pelgrims, J, et al.
Publicado: (2000)

Ifosfamide-Induced Encephalopathy Successfully Prevented by Methylene Blue: A Pediatric Case Report and Review of the Literature
por: Furui, Yu, et al.
Publicado: (2023)

Possible metabolic interaction between docetaxel and ifosfamide
por: Ando, Y
Publicado: (2000)

Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney
por: Han, Hyoung-Yun, et al.
Publicado: (2021)

Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
por: Kim, Young Il, et al.
Publicado: (2010)

Doxorubicin and ifosfamide for recurrent renal synovial sarcoma: The first case report in Indonesia
por: Fitra, Ahmad Fathira, et al.
Publicado: (2022)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
por: Park, Jeong-Yeol, et al.
Publicado: (2019)

Steroid-Responsive Recurrent Encephalopathy Associated with Subacute Thyroiditis
por: Chung, Yun Jae, et al.
Publicado: (2008)

Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report
por: Hamilton, Juliette E., et al.
Publicado: (2020)

Metabolism of ifosfamide during a 3 day infusion.
por: Hartley, J. M., et al.
Publicado: (1994)

Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2013)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature
por: Chain, Gabriel, et al.
Publicado: (2022)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.
por: Perren, T. J., et al.
Publicado: (1993)

A Regimen of Taxol, Ifosfamide, and Platinum for Recurrent Advanced Squamous Cell Cancer of the Anal Canal
por: Golub, Diana V., et al.
Publicado: (2011)

The influence of ifosfamide scheduling on acute nephrotoxicity in children.
por: English, M. W., et al.
Publicado: (1997)

Effect of Glutathione Depletion on Ifosfamide Nephrotoxicity in Rats
por: Garimella-Krovi, Sudha, et al.
Publicado: (2008)

Ifosfamide-induced Fanconi syndrome with diabetes insipidus
por: Leem, Ah Young, et al.
Publicado: (2014)

Karyomegalic interstitial nephropathy following ifosfamide therapy
por: Jayasurya, R., et al.
Publicado: (2016)

Reversible Encepahlopathy Induced by Ifosfamide with Brain Imaging
por: Ali Mohamed, Daoud, et al.
Publicado: (2021)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4km940j97aopfmukmgt11d9o88